Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Accounts Payable & Accrued Expense : ¥371 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Accounts Payable & Accrued Expense?

Jiangsu Lianhuan Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥426 Mil) to Dec. 2023 (¥450 Mil) but then declined from Dec. 2023 (¥450 Mil) to Mar. 2024 (¥371 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥401 Mil) to Dec. 2022 (¥490 Mil) but then declined from Dec. 2022 (¥490 Mil) to Dec. 2023 (¥450 Mil).

Jiangsu Lianhuan Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

324.12

381.18

400.65

490.33

449.62

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															439.74	476.01	426.36	449.62	371.24

Jiangsu Lianhuan Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009

Website

http://www.lhpharma.com

Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.

Executives

Chu Qing Song	senior management
Xia Chun Lai	Director
Pan He Ping	Directors, senior managers
Niu Ben	senior management
Wu Wen Ge	Director
Zhu Yong Jun	senior management
Qian Zhen Hua	Director
Shen Yi	senior management
Huang Wen Tao	senior management
Zhou Jun	senior management
Tu Bin	senior management
Qin Xiong Jian	senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines